Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;7(3):539-43.
doi: 10.1007/s11481-012-9346-3. Epub 2012 Feb 29.

Near-field quantification of complement receptor 1 (CR1/CD35) protein clustering in human erythrocytes

Affiliations

Near-field quantification of complement receptor 1 (CR1/CD35) protein clustering in human erythrocytes

Zachary J Lapin et al. J Neuroimmune Pharmacol. 2012 Sep.

Abstract

We investigate the distribution of the membrane protein complement receptor 1 (CR1/CD35) in human erythrocyte membrane ghosts using scanning near-field optical microscopy. Recent studies have demonstrated that levels of Aβ peptide, associated with Alzheimers disease (AD) and present in brain and peripheral blood, vary significantly when bound by complement C3b-dependent adherence to CR1. It is unknown why patients with AD have a markedly impaired ability to bind Aβ to CR1 via this mechanism, but one possibility is a defect in the localization and/or conformation of CR1 in the membrane. Scanning near-field optical microscopy does not require the harsh preparation of electron microscopy techniques and may therefore be better suited for measuring membrane protein distributions. The clustering phenomenon of CR1 identified in electron microscopy studies is confirmed and quantified. The standard deviation of the inter-cluster spacing of CR1 is constant (79 ± 9 nm) across erythrocytes with between 61 and 124 clusters per membrane ghost.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1989 Mar 15;142(6):2031-6 - PubMed
    1. J Immunol. 1988 Dec 1;141(11):3889-94 - PubMed
    1. Nano Lett. 2009 Feb;9(2):903-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10016-20 - PubMed
    1. Clin Exp Immunol. 1985 Mar;59(3):547-54 - PubMed

Substances

LinkOut - more resources